Sorry, you need to enable JavaScript to visit this website.
DeliverinG THE LATEST
GREENSTONE News

Get up-to-date product and event news, including information on our generic products.

GREENSTONE LLC INTRODUCES SILDENAFIL CITRATE TABLETS Authorized Generic of VIAGRA® (sildenafil citrate) Tablets

PEAPACK, NJ, December 2017—Greenstone LLC, a US-based subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of Sildenafil Citrate tablets to its ever-expanding generic pharmaceutical product line. The product is offered and available in presentations of 25 mg, 50 mg, and 100 mg tablets.
 
Read more »

URGENT: REVISED DRUG RECALL diphenoxylate hydrochloride and atropine sulfate tablets, USP – CV

 URGENT: REVISED DRUG RECALL
diphenoxylate hydrochloride and atropine sulfate tablets, USP – CV

NDC                    Lot Number            Expiration Date             Strength                      Configuration/Count
59762‐1061‐1     R83962                   2021 OCT 31               2.5 mg/0.025 mg         Bottle containing 100 tablets
59762‐1061‐1     R93347                   2021 OCT 31               2.5 mg/0.025 mg         Bottle containing 100 tablets
Read more »

GREENSTONE ISSUES VOLUNTARY NATIONWIDE RECALL OF DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE TABLETS, USP DUE TO POSSIBLE SUB POTENT AND SUPER POTENT TABLETS

Greenstone Issues Voluntary Nationwide Recall of Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP Due to Possible Sub Potent and Super Potent Tablets
 
 
Media Contact: 610-329-1340
 
 
For Immediate Release – PEAPACK, NJ, November 16, 2017 - Greenstone LLC, a wholly owned subsidiary of Pfizer Inc., is  voluntarily recalling multiple lots of diphenoxylate hydrochloride and atropine sulfate tablets, USP to the consumer level. Greenstone initiated this recall because product from these lots has the potential to be super potent or sub potent.Read more »

Important Product Expiration Date Information Regarding Medroxyprogesterone Acetate Injectable Suspension, USP

Medroxyprogesterone Acetate Injectable Suspension, USP, (pre-filled syringe) distributed by Greenstone LLC may contain two different product expiration dates printed on its individual components. Please note that the date printed on the outer carton of the combination pack should be considered as the overall expiration date of the combination product.

There are no known safety or labeling concerns which have been associated with this situation.

Read more »

GREENSTONE LLC INTRODUCES DOFETILIDE CAPSULES—Its Latest Generic Pharmaceutical Product

PEAPACK, NJ, June 2016—Greenstone LLC, a US-based subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of Dofetilide Capsules to its ever-expanding generic pharmaceutical product line. The product is offered and available in dosage strengths of 125 mcg (0.125 mg) x 60 capsules per bottle, 250 mcg (0.250 mg) x 60 capsules per bottle and 500 mcg (0.5 mg) x 60 capsules per bottle.

Read more »

GREENSTONE LLC INTRODUCES TOLTERODINE TARTRATE EXTENDED RELEASE CAPSULES—Its Latest Generic Pharmaceutical Product

PEAPACK, NJ, January 2016—Greenstone LLC, a US-based subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of tolterodine tartrate extended release capsules to its ever-expanding generic pharmaceutical product line. The product is offered in dosage strengths of 2 mg x 30 capsules per bottle, 2 mg x 90 capsules per bottle, 4 mg x 30 capsules per bottle, and 4 mg x 90 capsules per bottle.

Read more »

GREENSTONE LLC INTRODUCES COLESTIPOL HYDROCHLORIDE GRANULES FOR ORAL SUSPENSION—Its Latest Generic Pharmaceutical Product

PEAPACK, NJ, January 2016—Greenstone LLC, a US-based subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of Colestipol Hydrochloride Granules for Oral Suspension to its ever-expanding generic pharmaceutical product line. The product is offered and available in cartons of 30 foils of 5 grams each, cartons of 90 foils of 5 grams each, and bottles of 500 grams with scoop.

Read more »

GREENSTONE LLC INTRODUCES LINEZOLID TABLETS—Its Latest Generic Pharmaceutical Product

PEAPACK, NJ, December 2015 — Greenstone LLC, a U.S.-based subsidiary of Pfizer Inc (NYSE: PFE), is pleased to announce the introduction of linezolid tablets to its ever-expanding generic pharmaceutical product line. The product is offered in dosage strengths of 600 mg x 20 tablets per bottle and 600 mg x unit dose packages of 20 tablets.

Read more »

GREENSTONE LLC INTRODUCES LINEZOLID FOR ORAL SUSPENSION—Its Latest Generic Pharmaceutical Product

PEAPACK, NJ, November 2015 — Greenstone LLC, a U.S.-based subsidiary of Pfizer Inc (NYSE: PFE), is pleased to announce the introduction of linezolid for oral suspension to its ever-expanding generic pharmaceutical product line. The product is offered in powder form in dosage strengths of 100 mg / 5 mL x 150 mL as reconstituted suspension.

Read more »

GREENSTONE LLC INTRODUCES ETHOSUXIMIDE CAPSULES, USP / ETHOSUXIMIDE ORAL SOLUTION—Its Latest Generic Pharmaceutical Product

PEAPACK, NJ, October 2015 — Greenstone LLC, a U.S.-based subsidiary of Pfizer Inc (NYSE: PFE), is pleased to announce the introduction of ethosuximide capsules and ethosuximide oral solution to its ever-expanding generic pharmaceutical product line. The capsules are offered in dosage strength of 250 mg in bottles of 100 counts, and the oral solution in a dosage strength of 250 mg/5 mL as oral solution.

Read more »

GREENSTONE LLC INTRODUCES TRANDOLAPRIL / VERAPAMIL HYDROCHLORIDE ER TABLETS—Its Latest Generic Pharmaceutical Product

PEAPACK, N.J., February, 2015 — Greenstone LLC, a U.S.-based generic pharmaceutical subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of Trandolapril/Verapamil Hydrochloride Extended Release (ER) tablets to its ever-expanding generic pharmaceutical product line. The product is offered in dosage strengths of 1mg/240mg x 100; 2mg/180mg x100; 2mg/240mg x 100; 4mg/240mg x 100.

Read more »

GREENSTONE LLC INTRODUCES CELECOXIB CAPSULES—Its Latest Generic Pharmaceutical Product

PEAPACK, N.J., December 2014 — Greenstone LLC, a U.S.-based subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of CELECOXIB to its ever-expanding generic pharmaceutical product line. The product is offered in capsule form in dosage strengths of 50 mg x 60 capsules per bottle; 100 mg x 100 capsules per bottle; 100 mg x 500 capsules per bottle; 200 mg x 100 capsules per bottle; 200 mg x 500 capsules per bottle; and 400 mg x 60 capsules per bottle.

Read more »

GREENSTONE LLC INTRODUCES CABERGOLINE TABLETS—Its Latest Generic Pharmaceutical Product

PEAPACK, NJ, September 2014 — Greenstone LLC, a U.S.-based subsidiary of Pfizer Inc (NYSE: PFE), is pleased to announce the introduction of cabergoline tablets to its ever-expanding generic pharmaceutical product line. The product is offered in tablet form in dosage strengths of 0.5 mg x eight tablets per bottle.

Read more »

Product Recall

Pfizer initiates voluntary recall of two lots of Pfizer's EFFEXOR XR® 150 mg extended-release capsules and one lot of Greenstone's VENLAFAXINE HCL 150 mg extended-release capsules. Click here for more information.

Read more »